Advertisement
Screener

BIOMARIN PHARMACEUTICAL INC (BMRN) Increase (Decrease) in Other Noncurrent Assets

2.8 / 5 stars · 68/120 Roast Me

BIOMARIN PHARMACEUTICAL INC Increase (Decrease) in Other Noncurrent Assets

BIOMARIN PHARMACEUTICAL INC (BMRN) reported Increase (Decrease) in Other Noncurrent Assets of -$9.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06

  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$7.52M, a 163.30% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$1.48M, a 191.38% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $5.89M, a 85.92% decline year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $19.17M, a 114.02% increase year-over-year.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2025 was $38.57M, a 47.66% decline from fiscal 2024.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2024 was $73.70M, a 136.60% increase from fiscal 2023.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2023 was $31.15M, a 56.85% increase from fiscal 2022.
  • BIOMARIN PHARMACEUTICAL INC increase (decrease) in other noncurrent assets for fiscal 2022 was $19.86M, a 201.21% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 3 month as first filedIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 6 month as first filedIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 9 month as first filedIncrease (Decrease) in Other Noncurrent Assets 12 monthIncrease (Decrease) in Other Noncurrent Assets 12 month as first filed
2026-06-30-$7.52M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$9.01M
10-Q · filed 2026-08-06
-$3.11M
derived: sum of 3 quarters · filed 2026-08-06
$16.06M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$1.48M
10-Q · filed 2026-05-05
$4.41M
derived: sum of 2 quarters · filed 2026-05-05
$23.58M
derived: sum of 3 quarters · filed 2026-05-05
$35.47M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$5.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.07M
derived: sum of 2 quarters · filed 2026-02-26
$36.95M
derived: sum of 3 quarters · filed 2026-08-06
$38.57M
10-K · filed 2026-02-26
2025-09-30$19.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$31.05M
derived: sum of 2 quarters · filed 2026-08-06
$32.68M
10-Q · filed 2025-10-28
$74.54M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$11.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$13.51M
10-Q · filed 2026-08-06
$55.37M
derived: sum of 3 quarters · filed 2026-08-06
$64.33M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.62M
10-Q · filed 2026-05-05
$43.48M
derived: sum of 2 quarters · filed 2026-05-05
$52.44M
derived: sum of 3 quarters · filed 2026-05-05
$63.19M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-31$41.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$50.82M
derived: sum of 2 quarters · filed 2026-02-26
$61.57M
derived: sum of 3 quarters · filed 2026-02-26
$73.70M
10-K · filed 2026-02-26
2024-09-30$8.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$19.71M
derived: sum of 2 quarters · filed 2025-10-28
$31.84M
10-Q · filed 2025-10-28
$42.18M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$10.75M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$22.88M
10-Q · filed 2025-08-05
$33.22M
derived: sum of 3 quarters · filed 2026-02-26
$48.41M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$12.13M
10-Q · filed 2025-05-02
$22.47M
derived: sum of 2 quarters · filed 2026-02-26
$37.66M
derived: sum of 3 quarters · filed 2026-02-26
$42.96M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$10.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$25.53M
derived: sum of 2 quarters · filed 2026-02-26
$30.83M
derived: sum of 3 quarters · filed 2026-02-26
$31.15M
10-K · filed 2026-02-26
2023-09-30$15.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31
$20.49M
derived: sum of 2 quarters · filed 2024-10-31
$20.81M
10-Q · filed 2024-10-31
$52.81M
derived: sum of 4 quarters · filed 2025-02-24
2023-06-30$5.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05
$5.62M
10-Q · filed 2024-08-05
$37.62M
derived: sum of 3 quarters · filed 2025-02-24
$34.62M
derived: sum of 4 quarters · filed 2025-02-24
2023-03-31$323.00K
10-Q · filed 2024-04-26
$32.32M
derived: sum of 2 quarters · filed 2025-02-24
$29.33M
derived: sum of 3 quarters · filed 2025-02-24
$21.62M
derived: sum of 4 quarters · filed 2025-02-24
2022-12-31$32.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24
$29.01M
derived: sum of 2 quarters · filed 2025-02-24
$21.30M
derived: sum of 3 quarters · filed 2025-02-24
$19.86M
10-K · filed 2025-02-24
2022-09-30-$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$10.70M
derived: sum of 2 quarters · filed 2023-11-02
-$12.14M
10-Q · filed 2023-11-02
-$5.95M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$7.71M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02
-$9.15M
10-Q · filed 2023-08-02
-$2.96M
derived: sum of 3 quarters · filed 2024-02-26
-$2.23M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31-$1.44M
10-Q · filed 2023-04-28
$4.75M
derived: sum of 2 quarters · filed 2024-02-26
$5.47M
derived: sum of 3 quarters · filed 2024-02-26
$6.77M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31$6.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
$6.91M
derived: sum of 2 quarters · filed 2024-02-26
$8.21M
derived: sum of 3 quarters · filed 2024-02-26
$6.59M
10-K · filed 2024-02-26
2021-09-30$728.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28
$2.02M
derived: sum of 2 quarters · filed 2022-10-28
$407.00K
10-Q · filed 2022-10-28
$23.87M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$1.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$321.00K
10-Q · filed 2022-08-04
$23.14M
derived: sum of 3 quarters · filed 2023-02-27
$23.09M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31-$1.62M
10-Q · filed 2022-04-29
$21.85M
derived: sum of 2 quarters · filed 2023-02-27
$21.79M
derived: sum of 3 quarters · filed 2023-02-27
$26.95M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$23.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$23.41M
derived: sum of 2 quarters · filed 2023-02-27
$28.57M
derived: sum of 3 quarters · filed 2023-02-27
$29.01M
10-K · filed 2023-02-27
$28.65M
10-K · filed 2021-02-26
2020-09-30-$56.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29
$5.10M
derived: sum of 2 quarters · filed 2021-10-29
$5.54M
10-Q · filed 2021-10-29
$7.33M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$5.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
$5.60M
10-Q · filed 2021-07-30
$7.38M
derived: sum of 3 quarters · filed 2022-02-25
$9.90M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31$441.00K
10-Q · filed 2021-04-30
$2.22M
derived: sum of 2 quarters · filed 2022-02-25
$4.74M
derived: sum of 3 quarters · filed 2022-02-25
$11.56M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$1.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$4.30M
derived: sum of 2 quarters · filed 2022-02-25
$11.12M
derived: sum of 3 quarters · filed 2022-02-25
$8.89M
10-K · filed 2022-02-25
2019-09-30$2.52M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$9.33M
derived: sum of 2 quarters · filed 2020-11-06
$7.11M
10-Q · filed 2020-11-06
$4.90M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30$6.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$4.59M
10-Q · filed 2020-08-05
$2.38M
derived: sum of 3 quarters · filed 2021-02-26
-$920.00K
derived: sum of 4 quarters · filed 2021-02-26
2019-03-31-$2.22M
10-Q · filed 2020-05-01
-$4.43M
derived: sum of 2 quarters · filed 2021-02-26
-$7.73M
derived: sum of 3 quarters · filed 2021-02-26
-$2.38M
derived: sum of 4 quarters · filed 2021-02-26
2018-12-31-$2.21M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26
-$5.51M
derived: sum of 2 quarters · filed 2021-02-26
-$164.00K
derived: sum of 3 quarters · filed 2021-02-26
$935.00K
10-K · filed 2021-02-26
2018-09-30-$3.30M
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2019-11-04
$2.05M
derived: sum of 2 quarters · filed 2019-11-04
$3.15M
10-Q/A · filed 2019-11-04
$4.56M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$5.35M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$6.45M
10-Q · filed 2019-08-02
$7.86M
derived: sum of 3 quarters · filed 2020-02-27
$7.78M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$1.10M
10-Q · filed 2019-04-29
$2.51M
derived: sum of 2 quarters · filed 2020-02-27
$2.43M
derived: sum of 3 quarters · filed 2020-02-27
$3.01M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$1.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$1.33M
derived: sum of 2 quarters · filed 2020-02-27
$1.91M
derived: sum of 3 quarters · filed 2020-02-27
$2.44M
10-K · filed 2020-02-27
2017-09-30-$79.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$503.00K
derived: sum of 2 quarters · filed 2018-10-26
$1.03M
10-Q · filed 2018-10-26
$1.01M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30$582.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
$1.11M
10-Q · filed 2018-08-03
$1.09M
derived: sum of 3 quarters · filed 2019-02-28
$4.65M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31$527.00K
10-Q · filed 2018-04-27
$504.00K
derived: sum of 2 quarters · filed 2019-02-28
$4.07M
derived: sum of 3 quarters · filed 2019-02-28
$4.27M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$23.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28
$3.54M
derived: sum of 2 quarters · filed 2019-02-28
$3.75M
derived: sum of 3 quarters · filed 2019-02-28
$4.98M
10-K · filed 2019-02-28
2016-09-30$3.56M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
$3.77M
derived: sum of 2 quarters · filed 2017-10-31
$5.00M
10-Q · filed 2017-10-31
$6.77M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$207.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02
$1.44M
10-Q · filed 2017-08-02
$3.21M
derived: sum of 3 quarters · filed 2018-02-26
$5.09M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$1.23M
10-Q · filed 2017-05-04
$3.00M
derived: sum of 2 quarters · filed 2018-02-26
$4.89M
derived: sum of 3 quarters · filed 2018-02-26
$4.72M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$1.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$3.65M
derived: sum of 2 quarters · filed 2018-02-26
$3.49M
derived: sum of 3 quarters · filed 2018-02-26
$3.16M
10-K · filed 2018-02-26
2015-09-30$1.89M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$1.72M
derived: sum of 2 quarters · filed 2016-11-03
$1.39M
10-Q · filed 2016-11-03
$1.20M
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30-$167.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08
-$497.00K
10-Q · filed 2016-08-08
-$689.00K
derived: sum of 3 quarters · filed 2017-02-27
$1.38M
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31-$330.00K
10-Q · filed 2016-05-02
-$522.00K
derived: sum of 2 quarters · filed 2017-02-27
$1.55M
derived: sum of 3 quarters · filed 2017-02-27
$5.27M
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31-$192.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$1.88M
derived: sum of 2 quarters · filed 2017-02-27
$5.60M
derived: sum of 3 quarters · filed 2017-02-27
$6.52M
10-K · filed 2017-02-27
$6.43M
10-K · filed 2015-03-02
2014-09-30$2.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02
$5.79M
derived: sum of 2 quarters · filed 2015-11-02
$6.71M
10-Q · filed 2015-11-02
$6.72M
10-Q · filed 2014-10-28
$2.45M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$3.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05
$4.64M
10-Q · filed 2015-08-05
$4.67M
10-Q · filed 2014-07-31
$380.00K
derived: sum of 3 quarters · filed 2016-02-29
$302.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$920.00K
10-Q · filed 2015-05-05
$955.00K
10-Q · filed 2014-05-02
-$3.34M
derived: sum of 2 quarters · filed 2016-02-29
-$3.42M
derived: sum of 3 quarters · filed 2016-02-29
-$4.05M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31-$4.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
-$4.34M
derived: sum of 2 quarters · filed 2016-02-29
-$4.97M
derived: sum of 3 quarters · filed 2016-02-29
-$3.95M
10-K · filed 2016-02-29
-$1.68M
10-K · filed 2014-02-26
2013-09-30-$78.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-28
-$709.00K
derived: sum of 2 quarters · filed 2014-10-28
$307.00K
10-Q · filed 2014-10-28
-$2.52M
derived: sum of 4 quarters · filed 2015-03-02
2013-06-30-$631.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31
$385.00K
10-Q · filed 2014-07-31
-$2.44M
derived: sum of 3 quarters · filed 2015-03-02
-$1.77M
derived: sum of 4 quarters · filed 2015-03-02
2013-03-31$1.02M
10-Q · filed 2014-05-02
-$1.81M
derived: sum of 2 quarters · filed 2015-03-02
-$1.14M
derived: sum of 3 quarters · filed 2015-03-02
-$948.00K
derived: sum of 4 quarters · filed 2015-03-02
2012-12-31-$2.83M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02
-$2.16M
derived: sum of 2 quarters · filed 2015-03-02
-$1.96M
derived: sum of 3 quarters · filed 2015-03-02
$4.08M
10-K · filed 2015-03-02
2012-09-30$670.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-28
$865.00K
derived: sum of 2 quarters · filed 2013-10-28
$6.91M
10-Q · filed 2013-10-28
$7.85M
derived: sum of 4 quarters · filed 2014-02-26
2012-06-30$195.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-29
$6.24M
10-Q · filed 2013-07-29
$7.18M
derived: sum of 3 quarters · filed 2014-02-26
$8.82M
derived: sum of 4 quarters · filed 2014-02-26
2012-03-31$6.04M
10-Q · filed 2013-04-29
$6.99M
derived: sum of 2 quarters · filed 2014-02-26
$8.63M
derived: sum of 3 quarters · filed 2014-02-26
$8.48M
derived: sum of 4 quarters · filed 2014-02-26
2011-12-31$947.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26
$2.59M
derived: sum of 2 quarters · filed 2014-02-26
$2.44M
derived: sum of 3 quarters · filed 2014-02-26
$837.00K
10-K · filed 2014-02-26
2011-09-30$1.64M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-29
$1.49M
derived: sum of 2 quarters · filed 2012-10-29
-$110.00K
10-Q · filed 2012-10-29
$3.07M
derived: sum of 4 quarters · filed 2013-02-26
2011-06-30-$150.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02
-$1.75M
10-Q · filed 2012-08-02
$1.43M
derived: sum of 3 quarters · filed 2013-02-26
$931.00K
derived: sum of 4 quarters · filed 2013-02-26
2011-03-31-$1.60M
10-Q · filed 2012-04-30
$1.58M
derived: sum of 2 quarters · filed 2013-02-26
$1.08M
derived: sum of 3 quarters · filed 2013-02-26
2010-12-31$3.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26
$2.68M
derived: sum of 2 quarters · filed 2013-02-26
$5.33M
10-K · filed 2013-02-26
2010-09-30-$498.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31
$2.15M
10-Q · filed 2011-10-31
2010-06-30$2.65M
10-Q · filed 2011-08-01
2009-12-31$1.29M
10-K · filed 2012-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
Elanco Animal Health Inc (ELAN)United States$11.177B-61.80
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05